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Abstract
This chapter aims to present and discuss the main cell culture techniques used 
for the growth and maintenance of the different evolutionary forms of the proto-
zoan Trypanosoma cruzi, the etiologic agent of the Chagas disease. Chagas disease 
is a neglected tropical disease endemic in several Latin American countries. Here, 
we intend to present the main difficulties, advantages, and disadvantages of using 
Trypanosoma cruzi cell culture in parasitic biology. Finally, we present the main 
research opportunities in the context of Trypanosoma cruzi parasitic biology using 
cell culture techniques, such as drug development, characterization of pharmaco-
logical targets, molecular markers for diagnosis, structural biology, and many other 
biomedical applications.
Keywords: Trypanosoma cruzi, Chagas disease, cell culture, in vitro assay, 
metacyclogenesis
1. Introduction
Carlos Chagas described the American trypanosomiasis through micro-
scope observation of hemoflagellate protozoan in the sample blood and named 
Trypanosoma cruzi [1]. The parasite belongs to the Kinetoplastida order and 
Trypanosomatidae family. This family is characterized by the presence of flagel-
lum and only one mitochondrion, which extends throughout the cell body. The 
mitochondrion matrix contains a complex array of DNA fibrils structure called 
kinetoplast (kDNA).
Trypanosoma cruzi (T. cruzi) is a digenetic parasite that develops through a com-
plex life cycle involving an insect vector and a mammalian host. Trypanosomatidae 
family shows, during development stages, several forms, which can be easily identi-
fied by light microscopy in Giemsa-stained preparations. In the case of T. cruzi, three 
main morphogenetic forms are recognized, and the transition between each form 
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involves morphologic modifications in gene expression and cellular cycle (Table 1). 
Therefore, the evolutionary forms, trypomastigote and amastigote, are found in the 
vertebrate host, and epimastigote and metacyclic trypomastigotes are found in the 
invertebrate host [2].
Due to its genetic diversity, the parasite T. cruzi represents one of the best model 
organisms for studies of clonal evolution, with rare events of recombination and/or 
genetic hybridization. Molecular markers, like the mini-exon genes and the ribo-
somal DNA 24S, allow the characterization of T. cruzi lineages and the subdivision 
in seven discrete typing units (DTUs, from TcI to TcVI) [3, 4]. Parasite of T. cruzi 
diversity could be associated with adaptation and survives inside different hosts. 
Therefore, this genotypic variation among the different strains of T. cruzi from 
different geographical regions may explain the frequency of variability in different 
characteristics of parasitism, such as virulence, subclinical infection rate, clinical 
symptoms of infection, and susceptibility to antiparasitic drugs [5].
A century of its discovery, Chagas disease remains a cause of early mortality and 
morbidity in individuals at productive age in endemic areas, generating significant 
socioeconomic impact. The importance of parasite biology studies is undeniable. 
In this context, in vitro studies of T. cruzi offers the opportunity to understand 
the coordination of metabolic and cellular change as a response to environmental 
stimuli in a simple and well-characterized system.
2. How to maintain and cultivate Trypanosoma cruzi?
During life cycle, T. cruzi alternates among different morphological and func-
tional types and different hosts (mammals and triatomine bugs). Epimastigote 
replicative form can result in non-replicative and infective trypomastigote forms. 
Amastigote forms could be achieved by infected mammal cells. The adaptation 
mechanism of T. cruzi to environmental changes and diverse physicochemical 
conditions represents an important means of survival.
Substantial interest in understanding the cell biology of T. cruzi made possible 
its maintenance and growth in in vitro systems. Several methods have already been 
described for obtaining the different stages of the parasite, and these can be cul-
tured in non-defined axenic media, defined axenic media, and in various cell types.
The axenic cultures of T. cruzi were primarily established in different cell types 
and tissues with appropriate conditions that allowed the infection process and 
Evolutionary forms
Epimastigote
Trypomastigote 
metacyclic
Trypomastigote Amastigote
Localization Intestine of 
the vector and 
axenic culture
Rectal ampoule 
of vector axenic 
culture
Blood and 
intracellular spaces 
of vertebrate-host 
and cells culture
Inside the cells 
of vertebrate-
host and cells 
culture
Cell 
morphology
Elongate Elongate Elongate Spherical
Position of the 
kinetoplast
Near the 
nucleus
After the nucleus After the nucleus Near the nucleus
These evolutionary forms are identified by the relative position of the kinetoplast in relation to the nucleus.
Table 1. 
View in optical microscope of the various developmental stages of Trypanosoma cruzi: epimastigote, 
intracellular amastigote, trypomastigote metacyclic, and bloodstream forms.
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its survival [6]. During this period, metacyclogenesis process was observed and 
characterized through detailing all the cellular and/or behavioral transformations 
undergone by the parasite. By observing the biological changes undergone, key 
points during the process became possible to be determined that were later mim-
icked to facilitate the differentiation process [7].
Epimastigote forms are maintained in axenic conditions at 28°C, in the nutritive 
medium liver infusion tryptose (LIT), supplemented with 10% (v/v) heat- 
inactivated fetal bovine serum (FBS) as described by Camargo [8]. Under chemically 
defined conditions and suppression of nutrients, the transformation of epimas-
tigotes into metacyclic trypomastigotes is possible in vitro using a process named 
metacyclogenesis [9].
To obtain intracellular amastigote forms, usually mammal cells, Vero lineage, 
murine peritoneal macrophages, fibroblast (mouse L929), and primary heart or 
skeletal muscles cells are commonly incubated with specific medium supplemented 
with 10% inactivated FBS (v/v) and allowed to adhere usually for 24 h at 37 ± 2°C in 
5% CO2. After this period, adherent cells can infect with trypomastigote metacyclic 
using a 10:1 ratio of parasites per cell and incubated at 37°C in 5% CO2, without 
FBS. Amastigote can be observed in microscope at 4–24 h after infection. Intracellular 
amastigote can release within 72 h trypomastigote metacyclic from culture derived. 
Infected Vero cells can be in continuous cultivation during 6–8 weeks [10].
Infected cells with T. cruzi can spontaneously release amastigote forms into the 
supernatant medium. The viable amastigote forms can be collected and produce 
the axenic amastigote. Firstly, wash cells with phosphate buffer saline (PBS, pH 7.2) 
through centrifugation, collect, and then resuspend in appropriate medium, 
 usually Grace medium supplemented with nicotinamide and ATP. This addition can 
neutralize differentiation of amastigote forms, and the culture can be maintained at 
37°C in a humid atmosphere containing 5% CO2. Every 4 days, the media have to be 
partially removed by centrifugation to remove the supernatant medium and add the 
fresh medium to maintain the amastigote forms [11].
3.  In vitro differentiation of Trypanosoma cruzi epimastigote to 
trypomastigote forms
Metacyclic trypomastigotes (non-replicative) originating from the insect vector 
or trypomastigotes from infected cells, such as culture derived and bloodstream/
tissue, are infective forms of the parasite. Metacyclogenesis is observed in the 
stationary phase of culture, and metacyclic trypomastigotes are largely absent 
during logarithmic growth. However, in vitro differentiation of T. cruzi is possible 
according to biologically active factors and essential nutrient depletion or accu-
mulation of certain metabolites [12]. Generally, metacyclogenesis process can be 
mimicked using chemical differentiation medium or axenic-defined medium and 
nutrient suppression for the differentiation of the epimastigote forms to occur in 
trypomastigotes. The omission of medium supplements, such as glucose, was able to 
lead to flagellar elongation, as observe by Tyler and Engman [13]. The epimastigote-
extending flagellum occurs in order to undergo metacyclogenesis.
By contrast, chemical modification is commonly used for differentiation of epi-
mastigote to trypomastigote forms. Epimastigote forms can be collected from the 
LIT culture, during the stationary phase of the growth curve, and then resuspended 
in artificial triatomine urine (TAU) supplemented with proline (TAUP medium) 
or TAU supplemented with L-proline, L-sodium glutamate, L-sodium aspartate, 
and D-glucose (TAU3AAG medium) [14]. In the first medium, parasite culture 
can differentiate after 10 days and 72–96 h using TAU3AAG medium. Recent study 
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demonstrated that reductive environment using urate, a salt or ester of uric acid, 
could promote epimastigote differentiation with significant increment of trypo-
mastigotes [15]. In addition, Grace medium supplemented with Triatoma infestans 
intestinal homogenate was used for in vitro metacyclogenesis of T. cruzi [16].
Metacyclic trypomastigotes are essential for the understanding of host-pathogen 
interaction and it is remarkable genetic variability between strains. Although, these 
biological stages in axenic medium are difficult to purify, culture remains with epi-
mastigote stages without showing a high efficiency in the purification of metacyclic 
trypomastigotes [8].
Complement-mediated lysis of epimastigotes followed by separation of the 
trypomastigotes by gradient centrifugation through a dense albumin column 
represents a selective method that exploited to purify viable trypomastigotes from 
cells culture medium. Alternate pathway activation seems capable by itself generat-
ing epimastigote lysis and consequent activation of the classical pathway just in the 
presence of serum [17].
Other several techniques such as density separation with Percoll [18, 19] and 
extensive use of chromatography have permitted purifying metacyclic trypo-
mastigotes for the association of specific molecules expressed on this parasite 
stage membrane separation. Chromatography based on the differential plasma 
membrane charge between epimastigotes and trypomastigotes using ion exchange 
chromatography with resins, such as cellulose-DEAE and sephadex, have been 
developed for the purification of metacyclic trypomastigotes [20, 21]. These 
previous chromatography techniques presented a major disadvantage such as the 
decrease in the infective capacity of the obtained trypomastigote [22].
Recently, a new protocol in LIT medium cultures was implemented using sepharose-
DEAE as a resin during purification process, which could recover metacyclic 
trypomastigotes for two different DTUs (I and II). DTU TcI was the one recovered 
a greater amount of these forms, and parasite infectivity in vitro and in vivo was 
maintained [20]. Metacyclogenesis with different DTUs exhibited significantly 
different morphologies and metacyclogenesis pattern [23].
Still it remains crucial to have easy, fast, and reliable tools to obtain purified 
metacyclic trypomastigote forms of T. cruzi. Thus, results acquired with these puri-
fied parasites should be interpreted with caution in order to validated biological, 
chemical, or immunological studies.
4. Advantages and limitation of in vitro Trypanosoma cruzi culture
The entire T. cruzi cycle can be studied in vitro, and it is one of the easiest to 
keep in the laboratory. A crucial point, which is considered to be a basic require-
ment for all the biological assays in vitro system using T. cruzi is the selection of 
methods and adoption of biosafety procedures, including good laboratory facilities 
and laboratory practices and the use of collective and individual protection tools. 
Therefore, the training of personnel involved in the manipulation and cultivation of 
T. cruzi strains is required, especially on the handling of drug-resistant strains.
Probably, the main advantages of the use of in vitro systems for maintenance 
and cultivation of T. cruzi are related to costs and biosafety. The in vitro system of 
T. cruzi cultivation presents some characteristics that deserve to be highlighted:  
(i) reduction of the number of animals used in experimental models of infection, 
(ii) ethical aspects in animal replacement, (iii) less need for laboratory  
infrastructure, (iv) reduced time of experiments compared to in vivo methods, and 
(iv) lower risk of human infection during culture procedures [15].
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As mentioned above, the use of T. cruzi in in vitro assays allows the researcher to 
access a variety of strains with different biological and genetic profiles, in addi-
tion to the different stages of parasite differentiation. Furthermore, T. cruzi clones 
exhibit a greater rate of multiplication in culture medium.
One of the possibilities of in vitro system is to obtain large amounts of meta-
cyclic trypomastigotes (derived culture or chemical modification medium) with 
biological properties similar to those of the insect-derived forms, which facilitates 
the study of the biology of T. cruzi. On the other hand, there is a controversy that 
the strains are kept in artificial culture media, transformed into true “laboratory 
strains,” with total or partial loss of their original characteristics, despite their mor-
phological similarities. Contreras and colleagues demonstrated that culture-derived 
metacyclic forms of T. cruzi can decrease their capacity to invade cells [16].
The great potential of the in vitro models is the study of the interaction T. cruzi-
host cell throughout amastigote culture. It has been demonstrated the in vitro 
capacity of invasion in all cell types was tested [10, 24]. As yet, in vivo models, 
infected animals, as well as in human, show evidence of a parasite tropism by cells of 
the mononuclear phagocytic system and by muscle and nerve cells, contrary to what 
is observed in vitro as mentioned before. On the other hand, maintained trypomasti-
gote metacyclic in vivo (mice) condition generally increased virulence [14].
However, the in vitro assay does not provide full information on the behavior 
and characteristics about T. cruzi. The complexity of in vivo system is bigger than 
in parasite cultivation system. The mechanisms of parasite-host interaction are 
controlled by cells and innumerable proteins that trigger numerous genetic and 
physiological signals in the parasite. These interactions cannot be accurately evalu-
ated in in vitro systems.
5. Applications in the cell culture of Trypanosoma cruzi
Despite decades of research in T. cruzi biology, many questions remain to be 
solved. The cultivation of T. cruzi has been explored in several biomedical researches, 
mainly as a strategy for the understanding of parasite biology and parasite-host inter-
action. Thus, these in vitro methodologies have been used to understand mechanisms 
of parasite invasion, mechanisms of resistance and susceptibility to drugs, identifica-
tion of virulence factors, signaling, cellular metabolism, etc. Our research group has 
been using the T. cruzi cultures to evaluate the potential of new compounds with 
antiparasitic activity for the treatment of Chagas disease [25]. The cultivation meth-
ods also allow to isolate and characterize the circulating T. cruzi genotypes, present in 
triatomines captured in the natural environment of transmission of Chagas disease 
[26]. In addition, other robust molecular and structural biology tools can be applied 
to the study of the biology of T. cruzi using cell culture, namely, functional genomic 
and proteomic studies [27, 28] and structural cryo-microscopy [29].
6. Conclusion
In this chapter, we have shown the importance of cell culture techniques as a 
complementary tool for studies of parasitic biology. Through the cultivation of dif-
ferent evolutionary forms of T. cruzi, we can answer important scientific questions 
in the context of parasitic diseases, more specifically in Chagas disease. In conclu-
sion, this work shows a reflection about the advantages and limitations of T. cruzi 
cultivation techniques in studies of parasitic biology.
Biology of Trypanosoma cruzi
6
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Acknowledgements
CJGM, JWFO, and AMQ are grateful for the financial support provided by 
Capes/Brazil through postgraduate scholarships. MSS thanks Global Health and 
Tropical Medicine, Lisbon-Portugal (GHTM-UID/multi/04413/2013), and to 
Berenice Project supported by FP7 European Union (grant number 305937). We are 
also grateful to Paulo Fanado for editing this manuscript.
Conflict of interest
The authors declare no conflict of interest.
Author details
Cláudia Jassica Gonçalves Moreno1,2, Johny Wysllas de Freitas Oliveira1,2,  
Joice Castelo Branco1,3, Laura Araújo1,3, Aline Maria Queiroz1,3, Sílvia Tavares Donato1,4, 
Nilton José da Silva Júnior1, Emilly Thays da Silva Rodrigues1  
and Marcelo Sousa Silva1,2,3,4*
1 Immunoparasitology Laboratory, Health Sciences Centre, Federal University of 
the Rio Grande do Norte, Natal, Brazil
2 Biosciences Centre, Federal University of the Rio Grande do Norte, Natal, Brazil
3 Health Sciences Centre, Federal University of the Rio Grande do Norte, Natal, 
Brazil
4 Global Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, 
Universidade Nova de Lisboa, Lisbon, Portugal
*Address all correspondence to: mssilva@ihmt.unl.pt
7Cell Culture and Maintenance of the Evolutionary Forms of Trypanosoma cruzi for Studies…
DOI: http://dx.doi.org/10.5772/intechopen.84733
References
[1] Chagas C. Nova tripanomiaze 
humana. Estudos sobre a morfolojía e o 
ciclo evolutivo de Schizotrypanum cruzi 
n. gen., n. sp., ajente etiolójico de nova 
entidade morbida do homen. Memórias 
do Instituto Oswaldo Cruz. 1909. DOI: 
10.1590/S0074-02761909000200008
[2] De Souza W. Cell biology of 
Trypanosoma cruzi. International 
Review of Cytology. 1984. DOI: 10.1016/
S0074-7696(08)60180-1
[3] Zingales B et al. The revised 
Trypanosoma cruzi subspecific 
nomenclature: Rationale, 
epidemiological relevance and research 
applications. Infection, Genetics 
and Evolution. 2012. DOI: 10.1016/j.
meegid.2011.12.009
[4] Zingales B et al. A new consensus 
for Trypanosoma cruzi intraspecific 
nomenclature: Second revision meeting 
recommends TcI to TcVI. Memórias 
do Instituto Oswaldo Cruz. 2009. DOI: 
10.1590/S0074-02762009000700021
[5] Zingales B et al. Drug discovery 
for chagas disease should consider 
Trypanosoma cruzi strain diversity. 
Memórias do Instituto Oswaldo Cruz. 
2014. DOI: 10.1590/0074-0276140156
[6] Romana C et al. Study of the 
developmental cycle of Trypanosoma 
cruzi in fowl embryo tissue culture. 
Memórias do Instituto Oswaldo Cruz. 
1942;37(1):19-27
[7] Meyer H, de Oliveira MX. Cultivation 
of Trypanosoma cruzi in tissue cultures: 
A four-year study. Parasitology. 
1948;39(1-2):91-94
[8] Camargo E. Growth and 
differentiation in Trypanosoma cruzi. I.  
Origin of metacyclic trypanosomes 
in liquid media. Revista do Instituto 
de Medicina Tropical de São Paulo. 
1964;6:93-100
[9] Contreras VT, Salles JM, Thomas N,  
Morel CM, Goldenberg S. In vitro 
differentiation of Trypanosoma 
cruzi under chemically defined 
conditions. Molecular and 
Biochemical Parasitology. 1985. DOI: 
10.1016/0166-6851(85)90073-8
[10] Jorge TCA, Barbosa HS, Moreira AL, 
De Souza W, Meirelles MNL.  
The interaction of myotropic 
and macrophagotropic strains of 
Trypanosoma cruzi with myoblasts and 
fibers of skeletal muscle. Parasitology 
Research. 1986. DOI: 10.1007/
BF00925477
[11] Velasco JR, Adroher FJ, Osuna A.  
A survey of culture media of 
Trypanosoma cruzi amastigote 
forms from infected Vero cells. 
Chemosphere. 1989. DOI: 
10.1016/0045-6535(89)90518-3
[12] Tyler KM, Engman DM.  
Flagellar elongation induced by 
glucose limitation is preadaptive for 
Trypanosoma cruzi differentiation.  
Cell Motility and the Cytoskeleton. 
2000. DOI: 10.1002/1097-0169(200008) 
46:4<269::AID-CM4>3.0.CO;2-V
[13] Tyler KM, Engman DM. Flagellar 
elongation induced by glucose 
limitation is preadaptive for 
Trypanosoma cruzi differentiation. 
Cell Motility and the Cytoskeleton. 
2000;46(4):269-278
[14] Contreras VT et al. Biological 
aspects of the Dm 28c clone 
of Trypanosoma cruzi after 
metacyclogenesis in chemically 
defined media. Memórias do Instituto 
Oswaldo Cruz. 1988. DOI: 10.1590/
S0074-02761988000100016
[15] Nogueira NP et al. Proliferation and 
differentiation of Trypanosoma cruzi 
inside its vector have a new trigger: 
Biology of Trypanosoma cruzi
8
Redox status. PLoS One. 2015. DOI: 
10.1371/journal.pone.0116712
[16] Isola ELD, Lammel EM, 
Cappa SMG. Trypanosoma cruzi: 
Differentiation after interaction 
of epimastigotes and Triatoma 
infestans intestinal homogenate. 
Experimental Parasitology. 1986. DOI: 
10.1016/0014-4894(86)90039-1
[17] Nogueira N, Bianco C, Cohn Z.  
Studies on the selective lysis and 
purification of Trypanosoma cruzi. The 
Journal of Experimental Medicine. 
1975;142(1):224-229
[18] Castanys S, Osuna A, Gamarro F,  
Ruiz-Pérez LM. Purification of 
metacyclic forms of Trypanosoma 
cruzi by Percoll discontinuous 
gradient centrifugation. Parasite. 
1984;70(4):443-449
[19] Rimoldi MT, Katzin VJ, Gonzalez-
Cappa SM, de Bracco MME. Isolation 
by Percoll gradient centrifugation and 
radiolabeling of bloodstream forms of 
Trypanosoma cruzi. Revista Argentina de 
Microbiología. 1986;18(1):41-44
[20] Cruz-Saavedra L, Muñoz M, León 
C, Patarroyo MA, Arevalo G, Pavia P,  
et al. Purification of Trypanosoma 
cruzi metacyclic trypomastigotes 
by ion exchange chromatography in 
sepharose-DEAE, a novel methodology 
for host-pathogen interaction studies. 
Journal of Microbiological Methods. 
2017;142:27-32
[21] de Carvalho TU, de Souza W.  
Separation of amastigotes and 
trypomastigotes of Trypanosoma cruzi 
from cultured cells. Zeitschrift für 
Parasitenkunde. 1983;69(5):571-575
[22] Villalta FV, Leon W. Effect of 
purification by DEAE-cellulose 
column on infectivity of Trypanosoma 
cruzi blood forms. The Journal of 
Parasitology. 1979;65(1):188-189
[23] Abegg CP, de Abreu AP, da Silva JL, 
de Araujo SM, Gomes ML, Ferreira EC,  
et al. Polymorphisms of blood forms 
and in vitro metacyclogenesis of 
Trypanosoma cruzi I, II, and IV.  
Experimental Parasitology. 2017;176:8-15
[24] Romanha AJ et al. In vitro and 
in vivo experimental models for 
drug screening and development for 
Chagas disease. Memórias do Instituto 
Oswaldo Cruz. 2010. DOI: 10.1590/
S0074-02762010000200022
[25] Parente AMS et al. Analogs of the 
scorpion venom peptide Stigmurin: 
Structural assessment, toxicity, and 
increased antimicrobial activity. 
Toxins (Basel). 2018. DOI: 10.3390/
toxins10040161
[26] Ribeiro AR et al. Biological 
and molecular characterization of 
Trypanosoma cruzi strains from four 
states of Brazil. The American Journal 
of Tropical Medicine and Hygiene. 2018. 
DOI: 10.4269/ajtmh.16-0200
[27] Avila CC et al. Proteome-
wide analysis of Trypanosoma 
cruzi exponential and stationary 
growth phases reveals a subcellular 
compartment-specific regulation. 
Genes (Basel). 2018. DOI: 10.3390/
genes9080413
[28] Romagnoli BAA et al. Improvements 
in the CRISPR/Cas9 system for 
high efficiency gene disruption in 
Trypanosoma cruzi. Acta Tropica. 2018. 
DOI: 10.1016/j.actatropica.2017.11.013
[29] Brito Querido J, Mancera-Martinez 
E, Vicens Q , Bochler A, Chicher 
J, Simonetti A, et al. The cryo-EM 
structure of a novel 40S kinetoplastid-
specific ribosomal protein. Structure. 
2017;25(12):1785-1794. DOI: 10.1016/j.
str.2017.09.014
